Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS)

American Journal of Epidemiology

Volumn 143, Issue 4, 1996, Pages 374-379

  Armenian, Haroutune K ^a   Hoover, Donald R ^a   Rubb, Susan ^a   Metz, Sharon ^a   Martinez Maza, Otoniel ^b   Chmiel, Joan ^c   Kingsley, Lawrence ^d   Saah, Alfred ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

acquired immunodeficiency syndrome; lymphoma, non Hodgkin's; risk factors

Indexed keywords

ACETYLSALICYLIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PAIN; RISK FACTOR; SEXUAL BEHAVIOR;

EID: 0030019821     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008751     Document Type: Article

References (17)

1. Armenian HK, Hamadeh RR. Epidemiology of non-Hodgkin's lymphoma. In: Lilienfeld AM, ed. Reviews in cancer epidemiology. Vol 2. New York: Elsevier, 1983: 141-69.
2. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52: 5432-40.
3. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992;52:5566-9.
4. Pearce N, Bethwaite P. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. Cancer Res 1992;52:5496-500.
5. Filipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52:5465-7.
6. Beral V, Peterman T, Berkelman R, et al. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991;337:805-9.
7. Pluda JM, Yarchoan R, Broder S. HIV-associated non-Hodgkin's lymphomas. Ann Oncol 1991;2:248-9.
8. Bigger R, Rabkin C. The epidemiology of acquired immunodeficiency syndrome related lymphomas. Curr Opin Oncol 1992;4:883-93.
9. Moore RD, Kessler H, Richman DD, et al. Non-Hodgkin's lymphomas in patients with advanced HTV infection treated with zidovudine. JAMA 1991;265:2208-11.
10. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310-18.
11. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36(suppl 1):1S-15S.
12. Margolick JB, McArthur JC, Scott ER, et al. Flow cytometric quantitation of T cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus, type I. J Neuroimmunol 1988;20:73-81.
13. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary resuits from a case-control study in Los Angeles County. Cancer Res 1992;52:5510-15.
14. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol 1993;138:256-65.
15. Yawetz S, Cumberland WG, van der Meyden M, et al. Elevated serum levels of soluble CD23 (sCD23) precede the appearance of acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. Blood 1995;85:1843-9.
16. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994:266:1865-9.
17. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpes virus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332: 1186-91.